See more : Genflow Biosciences plc (GENF.L) Income Statement Analysis – Financial Results
Complete financial analysis of Sachem Capital Corp. 7.75% Note (SCCC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sachem Capital Corp. 7.75% Note, a leading company in the REIT – Mortgage industry within the Real Estate sector.
- Jai Corp Limited (JAICORPLTD.NS) Income Statement Analysis – Financial Results
- Mount Gibson Iron Limited (MTGRF) Income Statement Analysis – Financial Results
- PT Rukun Raharja Tbk (RAJA.JK) Income Statement Analysis – Financial Results
- FirstCash Holdings, Inc (FCFS) Income Statement Analysis – Financial Results
- Hangzhou Youngsun Intelligent Equipment Co., Ltd. (603901.SS) Income Statement Analysis – Financial Results
Sachem Capital Corp. 7.75% Note (SCCC)
About Sachem Capital Corp. 7.75% Note
Sachem Capital Corp. is a real estate finance company, which engages in the provision of real estate investment trust services. The firm specializes in originating, underwriting, funding, servicing, and managing services for a portfolio of short-term loans. It offers short-term, secured, and non-banking loans to real estate investors to fund their acquisition, renovation, rehabilitation, or development of residential and commercial properties. The company was founded by Jeffrey C. Villano and John L. Villano in January 2016 and is headquartered in Branford, CT.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 30.04B | 30.62B | 20.00B | 13.06B | 10.18B |
Cost of Revenue | 88.12M | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 29.95B | 30.62B | 20.00B | 13.06B | 10.18B |
Gross Profit Ratio | 99.71% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.82B | 3.10B | 2.24B | 1.19B | 1.02B |
Selling & Marketing | 6.93B | 5.32B | 3.12B | 1.80B | 1.53B |
SG&A | 11.75B | 8.41B | 5.37B | 2.99B | 2.56B |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 11.75B | 8.41B | 5.37B | 2.99B | 2.56B |
Cost & Expenses | 11.75B | 8.41B | 5.37B | 2.99B | 2.56B |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | -2.39B | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | 15.90B | 22.21B | 14.64B | 10.06B | 7.63B |
EBITDA Ratio | 52.93% | 72.53% | 73.17% | 77.09% | 74.90% |
Operating Income | 18.29B | 22.21B | 14.64B | 10.06B | 7.63B |
Operating Income Ratio | 60.89% | 72.53% | 73.17% | 77.09% | 74.90% |
Total Other Income/Expenses | -2.39B | -1.30B | -1.32B | -1.07B | -1.43B |
Income Before Tax | 15.90B | 20.91B | 13.32B | 8.99B | 6.20B |
Income Before Tax Ratio | 52.93% | 68.28% | 66.59% | 68.89% | 60.85% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 12.10B | 20.91B | 13.32B | 8.99B | 6.20B |
Net Income Ratio | 40.29% | 68.28% | 66.59% | 68.89% | 60.85% |
EPS | 273.56 | 0.55 | 0.51 | 0.41 | 0.32 |
EPS Diluted | 273.56 | 0.55 | 0.51 | 0.41 | 0.32 |
Weighted Avg Shares Out | 44.24M | 37.75M | 26.32M | 22.12M | 19.42M |
Weighted Avg Shares Out (Dil) | 44.24M | 37.75M | 26.32M | 22.12M | 19.42M |
Source: https://incomestatements.info
Category: Stock Reports